144 related articles for article (PubMed ID: 30946932)
21. Clinical outcome and expression of mutant P53, P16, and Smad4 in lung adenocarcinoma: a prospective study.
Bian C; Li Z; Xu Y; Wang J; Xu L; Shen H
World J Surg Oncol; 2015 Mar; 13():128. PubMed ID: 25890228
[TBL] [Abstract][Full Text] [Related]
22. Smad4/Fascin index is highly prognostic in patients with diffuse type EBV-associated gastric cancer.
Son BK; Kim DH; Min KW; Kim EK; Kwon MJ
Pathol Res Pract; 2018 Apr; 214(4):475-481. PubMed ID: 29572117
[TBL] [Abstract][Full Text] [Related]
23. AKR1B10, a good prognostic indicator in gastric cancer.
Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; He XJ; Xia YJ; Tao HQ; Shao QS
Eur J Surg Oncol; 2014 Mar; 40(3):318-24. PubMed ID: 24406159
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer.
Jia X; Shanmugam C; Paluri RK; Jhala NC; Behring MP; Katkoori VR; Sugandha SP; Bae S; Samuel T; Manne U
Oncotarget; 2017 Mar; 8(12):20198-20212. PubMed ID: 28423626
[TBL] [Abstract][Full Text] [Related]
25. Genetic changes in Slovenian patients with gastric adenocarcinoma evaluated in terms of microsatellite DNA.
Gazvoda B; Juvan R; Zupanic-Pajnic I; Repse S; Ferlan-Marolt K; Balazic J; Komel R
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1082-9. PubMed ID: 17998833
[TBL] [Abstract][Full Text] [Related]
26. Gastric Adenocarcinoma with Enteroblastic Differentiation Resected through Endoscopic Submucosal Dissection: A Case Report.
Ishikawa A; Nakamura K
Case Rep Gastroenterol; 2024; 18(1):68-73. PubMed ID: 38333765
[TBL] [Abstract][Full Text] [Related]
27. A study of Smad4 and Smad7 expression in surgically resected samples of gastric adenocarcinoma and their correlation with clinicopathological parameters and patient survival.
Zizi-Sermpetzoglou A; Myoteri D; Arkoumani E; Voultsos M; Marinis A
J BUON; 2014; 19(1):221-7. PubMed ID: 24659668
[TBL] [Abstract][Full Text] [Related]
28. Inactivation of Smad4 in gastric carcinomas.
Powell SM; Harper JC; Hamilton SR; Robinson CR; Cummings OW
Cancer Res; 1997 Oct; 57(19):4221-4. PubMed ID: 9331080
[TBL] [Abstract][Full Text] [Related]
29. Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression.
Wang LH; Kim SH; Lee JH; Choi YL; Kim YC; Park TS; Hong YC; Wu CF; Shin YK
Clin Cancer Res; 2007 Jan; 13(1):102-10. PubMed ID: 17200344
[TBL] [Abstract][Full Text] [Related]
30. ARID1A expression in gastric adenocarcinoma: clinicopathological significance and correlation with DNA mismatch repair status.
Inada R; Sekine S; Taniguchi H; Tsuda H; Katai H; Fujiwara T; Kushima R
World J Gastroenterol; 2015 Feb; 21(7):2159-68. PubMed ID: 25717252
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S
Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of the deleted in colorectal cancer gene protein expression in high-risk resected gastric carcinoma.
Bamias AT; Bai MC; Agnantis NJ; Michael MC; Alamanos YP; Stefanaki SV; Razi ED; Skarlos DV; Kappas AM; Pavlidis NA
Cancer Invest; 2003 Jun; 21(3):333-40. PubMed ID: 12901278
[TBL] [Abstract][Full Text] [Related]
33. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
34. Smad4/Smad7 balance: a role of tumorigenesis in gastric cancer.
Leng A; Liu T; He Y; Li Q; Zhang G
Exp Mol Pathol; 2009 Aug; 87(1):48-53. PubMed ID: 19341727
[TBL] [Abstract][Full Text] [Related]
35. Smad4 expression in gastric adenoma and adenocarcinoma: frequent loss of expression in diffuse type of gastric adenocarcinoma.
Kim JY; Park DY; Kim GH; Choi KU; Lee CH; Huh GY; Sol MY; Song GA; Jeon TY; Kim DH; Sim MS
Histol Histopathol; 2005 Apr; 20(2):543-9. PubMed ID: 15736060
[TBL] [Abstract][Full Text] [Related]
36. Molecular clonality analysis of esophageal adenocarcinoma by multiregion sequencing of tumor samples.
van Nistelrooij AM; van Marion R; Koppert LB; Biermann K; Spaander MC; Tilanus HW; van Lanschot JJ; Wijnhoven BP; Dinjens WN
BMC Res Notes; 2017 Apr; 10(1):144. PubMed ID: 28376920
[TBL] [Abstract][Full Text] [Related]
37. Gastric adenocarcinoma with enteroblastic differentiation followed endoscopically: A case report.
Kimura T; Hikichi T; Nakamura J; Takasumi M; Hashimoto M; Kato T; Kobashi R; Takagi T; Suzuki R; Sugimoto M; Sato Y; Irie H; Saze Z; Kobayakawa M; Kono K; Ohira H
Clin J Gastroenterol; 2020 Dec; 13(6):1074-1082. PubMed ID: 32875425
[TBL] [Abstract][Full Text] [Related]
38. Low-grade gastric adenomas/dysplasias: phenotypic expression, DNA ploidy pattern, and LOH at microsatellites linked to the APC gene.
Tanaka A; Takemura-Tsukashita S; Kushima R; Sugihara H; Fujiyama Y; Hattori T
Pathol Res Pract; 2008; 204(1):1-9. PubMed ID: 17964080
[TBL] [Abstract][Full Text] [Related]
39. Methylation of the claudin‑3 promoter predicts the prognosis of advanced gastric adenocarcinoma.
Zhang Z; Yu W; Chen S; Chen Y; Chen L; Zhang S
Oncol Rep; 2018 Jul; 40(1):49-60. PubMed ID: 29749528
[TBL] [Abstract][Full Text] [Related]
40. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]